Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Materials
Create a narrative
H.B. Fuller
NYSE:FUL Community
1
Narratives
written by author
0
Comments
on narratives written by author
3
Fair Values set
on narratives written by author
Create a narrative
H.B. Fuller
Popular
Undervalued
Overvalued
H.B. Fuller
WA
Analyst Price Target
Consensus Narrative from 6 Analysts
Reducing Costs And Leveraging Medical Adhesive Acquisitions Will Improve Future Prospects
Key Takeaways Cost savings from reducing manufacturing footprint and restructuring efforts are expected to enhance net margins and profitability. Strategic acquisitions and divestitures are set to strengthen market position in high-margin sectors, boosting revenue and EBITDA growth.
View narrative
US$71.83
FV
20.2% undervalued
intrinsic discount
2.20%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
23 days ago
author updated this narrative
Your Valuation for
FUL
H.B. Fuller
Your Fair Value
US$
Current Price
US$57.33
39.0% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
4b
2015
2018
2021
2024
2025
2027
2030
Revenue US$3.9b
Earnings US$141.3m
Advanced
Set as Fair Value